| 1 |
25401976 | FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis. | 2015 Feb 20 |
1 |
| 2 |
18850315 | Progesterone inhibits human endothelial cell proliferation through a p53-dependent pathway. | 2008 Nov |
1 |
| 3 |
15647429 | Increased Bcl-2/p53 ratio in human osteoarthritic cartilage: a possible role in regulation of chondrocyte metabolism. | 2005 Feb |
1 |
| 4 |
12782403 | Activation of insulin-like growth factor II signaling by mutant type p53: physiological implications for potentiation of IGF-II signaling by p53 mutant 249. | 2003 May 30 |
1 |
| 5 |
14695155 | Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin. | 2003 Dec 15 |
1 |
| 6 |
11980662 | The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates. | 2002 May 1 |
1 |
| 7 |
12224020 | p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma. | 2002 Oct |
1 |
| 8 |
10226585 | Differences in the biological effects of in vitro irradiation by 65 MeV protons and 137cesium gamma-rays. | 1999 Jan-Feb |
1 |
| 9 |
10421546 | Paclitaxel sensitivity correlates with p53 status and DNA fragmentation, but not G2/M accumulation. | 1999 Jul 15 |
1 |
| 10 |
9468185 | Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. | 1998 Feb 9 |
1 |
| 11 |
9607592 | Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity. | 1998 May |
1 |
| 12 |
8668331 | Acute and delayed apoptosis induced by thymidine deprivation correlates with expression of p53 and p53-regulated genes in colon carcinoma cells. | 1996 May 16 |
2 |
| 13 |
8774641 | Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro. | 1996 Mar |
1 |
| 14 |
8886839 | Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. | 1996 Sep 10 |
1 |
| 15 |
8979269 | Clonal variation of p53 expression and proliferative phenotype in A253 squamous carcinoma cells. | 1996 |
1 |
| 16 |
9552394 | Cellular responses to antimetabolite anticancer agents: cytostasis versus cytotoxicity. | 1996 |
1 |
| 17 |
9816160 | Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers. | 1996 Dec |
1 |
| 18 |
7560890 | Detection of P53 expression and S-phase cell fraction in paraffin-embedded tissue by a double-labeling technique. | 1995 Oct |
4 |
| 19 |
7616356 | p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. | 1995 May |
1 |
| 20 |
7627557 | Elevated levels of wild-type p53 induced by radiolabeling of cells leads to apoptosis or sustained growth arrest. | 1995 Apr 1 |
1 |
| 21 |
1322785 | p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. | 1992 Aug 15 |
1 |
| 22 |
1873816 | Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. | 1991 Sep 1 |
1 |